The expression of FOXO1 was enhanced in superficial bladder cancer when compared with invasive cancer, and compared with the high-grade group (grade 3), expression of FOXO1 was higher in low-grade bladder cancer (grade 1-2) [23]. This evidence concerns the gene FOXO1 and urinary bladder cancer.